Victory Capital Management
UPB

Victory Capital Management’s Upstream Bio Inc UPB Stock Holding History

Victory Capital Management’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,866
Closed -$233K – 2577
2026
Q1 		$233K Buy
+25,866
New +$465K ﹤0.01% 2172

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Victory Capital Management's UPB Position: Q2 2026 in Review

Victory Capital Management sold out of Upstream Bio Inc (UPB) in Q2 2026, closing a stake of 25,866 shares — an estimated $233K sold.

Victory Capital Management first reported a position in UPB in Q1 2026 and held it in 1 quarter. The position peaked at $233K in Q1 2026. 149 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Victory Capital Management reported no remaining Upstream Bio Inc position as of Q2 2026 after selling out during the quarter.
  • Victory Capital Management sold 25,866 Upstream Bio Inc shares in Q2 2026, an estimated $233K.
  • Victory Capital Management first reported a position in Upstream Bio Inc in Q1 2026 and held it in 1 quarter.
  • Victory Capital Management's Upstream Bio Inc position peaked at $233K in Q1 2026.
  • 149 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.